Aug 11, 99
|
| 12:30 ET |
SIBIA Neurosciences, Inc. Reports Financial Results For Second Quarter 1999
|
|
Aug 02, 99
|
| 09:04 ET |
Merck Acquires SIBIA Neurosciences, Inc., a California-Based Biotechnology Firm; Acquisition Augments Merck's Drug Discovery Program
|
|
Jul 21, 99
|
| 08:30 ET |
SIBIA Neurosciences Announces Results From Two Phase 2 Studies Of SIB-1508Y for Parkinson's Disease
|
|
Jul 15, 99
|
| 08:31 ET |
SIBIA Neurosciences Licenses Patented Transcription Based Assay Technology to Pharmacia & Upjohn
|
|
Jun 24, 99
|
| 08:30 ET |
SIBIA Neurosciences, Inc. Announces License of Patented Transcription-Based Assay Technology to American Home Products Corporation
|
|
May 28, 99
|
| 08:30 ET |
SIBIA Neurosciences, Inc. Announces Filing of Counterclaim Against Pfizer Inc. for Patent Infringement
|
|
May 26, 99
|
| 08:35 ET |
SIBIA Neurosciences and Lilly Announce Nicotinic Receptor Drug Discovery and Development Collaboration Focusing on Central Nervous System Disorders
|
|
May 13, 99
|
| 08:01 ET |
SIBIA Neurosciences, Inc. Announces Suit Filed by Pfizer, Inc.
|
|
May 07, 99
|
| 08:00 ET |
SIBIA Neurosciences, Inc. Reports Financial Results for the First Quarter Ended March 31, 1999
|
|
May 05, 99
|
| 08:03 ET |
SIBIA Neurosciences, Inc. Names Carla M. Suto, Ph.D. Vice President, HTS and Technology Development
|
|
Apr 14, 99
|
| 08:02 ET |
SIBIA Neurosciences, Inc. Announces License of Patented Transcription Based Assay Technology to SmithKline Beecham
|
|
Mar 30, 99
|
| 08:02 ET |
SIBIA Neurosciences, Inc. Announces License of Patented Transcription Based Assay Technology to Bristol-Myers Squibb
|
|
Mar 29, 99
|
| 08:01 ET |
SIBIA Neurosciences, Inc. Reports Novel Findings on Selective Compounds
|
|
Mar 26, 99
|
| 08:00 ET |
SIBIA Neurosciences, Inc. Reports Financial Results for Year-End and Fourth Quarter Ended December 31, 1998
|
|
Mar 15, 99
|
| 08:06 ET |
SIBIA Neurosciences Announces Issuance of United States Patents
|
|
Feb 01, 99
|
| 15:15 ET |
SIBIA Neurosciences Obtains a Permanent Injunction Against Cadus
|
|
Jan 19, 99
|
| 13:15 ET |
SIBIA Neurosciences Announces Granting of Key Foreign Patents for Technology Involved in its Recent Successful Litigation Against Cadus Pharmaceuticals, Inc.
|
|
Jan 07, 99
|
| 08:03 ET |
SIBIA Neurosciences Completes Phase 1 Multiple Dose Study of SIB-1553A and Initiates Phase 2 Study in Alzheimer's Disease Patients
|
|
Jan 04, 99
|
| 08:00 ET |
SIBIA Neurosciences Initiates Second Phase 2 Study Of SIB-1508Y for Parkinson's Disease
|
|
Dec 21, 98
|
| 08:02 ET |
SIBIA Neurosciences Awarded $18 Million Verdict in Patent Infringement Lawsuit Against Cadus Pharmaceutical Corp.
|
|
Nov 16, 98
|
| 11:45 ET |
SIBIA Neurosciences, Inc. Reports on Progress in All Drug Discovery Programs at the Society for Neuroscience Meeting
|
|
Nov 11, 98
|
| 19:13 ET |
SIBIA Neurosciences, Inc. Names Stephen F. Keane Vice President, Corporate Development
|
|
Nov 10, 98
|
| 19:16 ET |
SIBIA Neurosciences, Inc. Reports Financial Results for Third Quarter Ended September 30, 1998
|
|
Nov 04, 98
|
| 19:47 ET |
SIBIA Neurosciences Reports Neuroprotective Potential of Neuronal Nicotinic Acetylcholine Receptor Ligands
|
|
Oct 12, 98
|
| 19:47 ET |
SIBIA Neurosciences Announces Issuance of United States Patents
|
|
Aug 24, 98
|
| 06:14 ET |
SIBIA Neurosciences, Inc. Announces Favorable Court Orders Regarding Its Transcription Based Assay Patent
|
|
Jul 31, 98
|
| 06:17 ET |
SIBIA Neurosciences, Inc. Reports Financial Results For Second Quarter 1998
|
|
|